Source:http://linkedlifedata.com/resource/pubmed/id/16361317
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-12-27
|
pubmed:abstractText |
Fas-mediated apoptosis plays an important role in the immune system, including the elimination of autoreactive lymphoid cells. The Fas-mediated signaling pathway is classified into two types, type I and type II, in human lymphoid cell lines. We investigated whether a humanized anti-human Fas mAb, R-125224, has cell selectivity in induction of apoptosis. R-125224 induced apoptosis in H9 cells, SKW6.4 cells and activated human lymphocytes when cross-linked with anti-human IgG. On the other hand, R-125224 did not induce apoptosis in HPB-ALL cells, Jurkat cells or human hepatocytes. By analysis of death-inducing signaling complex formation, it was demonstrated that R-125224 induced apoptosis selectively in type I cells but not in type II cells. Type I cells also expressed more Fas and had more Fas-clustering activity than type II cells. Moreover, co-localization of these clusters and GM1, which is an sphingoglycolipid associated with lipid rafts, was detected. It was also shown that R-125224 treatment could reduce the number of activated human CD3+Fas+ cells in a SCID mouse model in vivo. Thus, we demonstrated that R-125224 induces apoptosis specifically in type I cells in vitro and in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0953-8178
|
pubmed:author |
pubmed-author:IchikawaKimihisaK,
pubmed-author:KomaiTomoakiT,
pubmed-author:NakayamaJunichiJ,
pubmed-author:OgawaYukieY,
pubmed-author:OhtsukiMasahikoM,
pubmed-author:OnozawaYoshikoY,
pubmed-author:SaitoMotokoM,
pubmed-author:TatsutaToruT,
pubmed-author:YamotoTakashiT,
pubmed-author:YonemuraAkikoA,
pubmed-author:YoshigaeYasushiY
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
113-24
|
pubmed:meshHeading |
pubmed-meshheading:16361317-Animals,
pubmed-meshheading:16361317-Antibodies, Monoclonal,
pubmed-meshheading:16361317-Antigens, CD3,
pubmed-meshheading:16361317-Antigens, CD95,
pubmed-meshheading:16361317-Apoptosis,
pubmed-meshheading:16361317-Hepatocytes,
pubmed-meshheading:16361317-Humans,
pubmed-meshheading:16361317-Immunologic Capping,
pubmed-meshheading:16361317-Jurkat Cells,
pubmed-meshheading:16361317-Lymphocyte Activation,
pubmed-meshheading:16361317-Mice,
pubmed-meshheading:16361317-Mice, SCID,
pubmed-meshheading:16361317-Signal Transduction,
pubmed-meshheading:16361317-Th1 Cells,
pubmed-meshheading:16361317-Th2 Cells
|
pubmed:year |
2006
|
pubmed:articleTitle |
A humanized anti-human Fas antibody, R-125224, induces apoptosis in type I activated lymphocytes but not in type II cells.
|
pubmed:affiliation |
Biological Research Laboratories, Sankyo Co., Ltd, Tokyo 140-8710, Japan.
|
pubmed:publicationType |
Journal Article
|